Previous 10 | Next 10 |
2023-11-09 07:09:58 ET More on Xtant Medical Seeking Alpha’s Quant Rating on Xtant Medical Historical earnings data for Xtant Medical Financial information for Xtant Medical For further details see: Xtant Medical GAAP EPS of $0.07 beats by $0.09, r...
BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, ...
BELGRADE, Mont., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended Se...
2023-10-23 16:29:44 ET More on Xtant Medical Seeking Alpha’s Quant Rating on Xtant Medical Historical earnings data for Xtant Medical Financial information for Xtant Medical For further details see: Xtant Medical acquires of nanOss production opera...
Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, to...
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products ...
BELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it completed the acquisition of certain assets and liabilities relat...
2023-08-01 12:38:14 ET Xtant Medical Holdings, Inc. (XTNT) Q2 2023 Earnings Conference Call August 01, 2023 09:00 AM ET Company Participants Matt Steinberg - IR Sean Browne - CEO Scott Neils - CFO Conference Call Participants Chase Knickerbocker - Cra...
2023-08-01 07:05:34 ET Xtant Medical press release ( NYSE: XTNT ): Q2 GAAP EPS of -$0.02 in-line. Revenue of $20.23M (+32.4% Y/Y) beats by $0.73M . Xtant Medical raises its expectation for full year 2023 revenue to $75 million to $77 million, up from the Compa...
Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported fin...
News, Short Squeeze, Breakout and More Instantly...
Xtant Medical Holdings Inc. Company Name:
XTNT Stock Symbol:
NYSE Market:
Xtant Medical Holdings Inc. Website:
BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief...
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial a...
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2...